Bank of America initiated coverage on shares of Guardant Health (NASDAQ:GH) in a report issued on Monday, MarketBeat.com reports. The brokerage issued a neutral rating and a $37.00 price target on the stock.
Shares of GH stock opened at $34.23 on Monday. Guardant Health has a 12-month low of $27.04 and a 12-month high of $44.25.
About Guardant Health
Guardant Health, Inc is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.
Recommended Story: What is a Tariff?
Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.